CHM 0.00% 1.8¢ chimeric therapeutics limited

Ann: Chimeric partnering with Cell Therapies Australia, page-15

  1. 48 Posts.
    lightbulb Created with Sketch. 27
    don’t think an IMU buyout is likely. Even tho I’m sure IMU is interested in CHMs portfolio and Leslie Chong was on the CHM Board not so long ago, IMU needs to conserve their cash - given their current cash burn of $20million per quarter they are quickly running out of their own cash run way. In fact, I would suggest an IMU CR is not too far away.

    I agree with steini that a RAD style placement with big pharma is most likely. Perhaps Novartis and I would expect at a significant premium to the current SP. time will tell!
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.8¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $18.06K 976.5K

Buyers (Bids)

No. Vol. Price($)
3 1080560 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 93000 1
View Market Depth
Last trade - 16.10pm 12/08/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.